Sutro Biopharma (STRO) USD0.001

Sell:$1.00Buy:$1.28$0.08 (5.60%)

NASDAQ:1.96%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.00
Buy:$1.28
Change:$0.08 (5.60%)
Market closed | Prices delayed by at least 15 minutes
Sell:$1.00
Buy:$1.28
Change:$0.08 (5.60%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 March 2025
William Joseph (Bill) NewellCEO
Sell
Tax related
6,708$1.36$9,122.88292,531
5 March 2025
Edward C AlbiniCFO
Sell
Tax related
3,594$1.36$4,887.84132,081
5 March 2025
Linda A FitzpatrickChief Level Officer
Sell
Tax related
3,594$1.36$4,887.8495,433
4 March 2025
William Joseph (Bill) NewellCEO
Sell
Tax related
11,136$1.42$15,813.12280,489
4 March 2025
Edward C AlbiniCFO
Sell
Tax related
3,748$1.42$5,322.16126,925
4 March 2025
Jane ChungPresident/COO
Sell
Tax related
2,334$1.42$3,314.2898,308
4 March 2025
Linda A FitzpatrickChief Level Officer
Sell
Tax related
3,748$1.42$5,322.1690,277
1 March 2025
William Joseph (Bill) NewellCEO
Sell
Tax related
25,203$1.59$40,072.77260,500
1 March 2025
Edward C AlbiniCFO
Sell
Tax related
10,320$1.59$16,408.80121,548
1 March 2025
Jane ChungPresident/COO
Sell
Tax related
9,450$1.59$15,025.5092,767

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 September 2024
Hans-Peter GerberChief Level Officer
Sell
Tax related
13,380$3.95$52,851.0024,120
1 March 2025
William Joseph (Bill) NewellCEO
Sell
Tax related
25,203$1.59$40,072.77260,500
11 April 2024
Venkatesh SrinivasanCTO
Sell
Tax related
7,582$4.50$34,119.0030,122
28 February 2025
Anne Elizabeth BorgmanOther Level A
Sell
Tax related
15,405$1.59$24,493.9546,469
1 December 2024
Jane ChungPresident/COO
Sell
Tax related
8,920$2.69$23,994.8070,342

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.